The device uses lasers to accelerate electrons along an etched channel.
In a full-scale particle accelerator, electrons fly along a kilometers-long path as microwaves bombard them, boosting the particles to near light speed. Such a high-energy electron beam, produced at facilities such as California’s SLAC National Accelerator Laboratory, enables a variety of experiments, including capturing extremely detailed images and probing the structures of molecules. But particle accelerators are expensive, require scientists to travel from locations all over the world and cannot accommodate all the researchers who submit requests to book time. To make these devices more accessible, a team at Stanford University developed a laser-driven particle accelerator that fits on a tiny silicon chip—and that could eventually be scaled up to produce a beam with as much energy as SLAC’s.
“The idea of using lasers in accelerators goes all the way back to the year the laser was invented, 1960,” says Robert Byer, a Stanford researcher who has been working on this concept since 1974. Lasers produce electromagnetic waves with much shorter wavelengths than the microwaves used in a full-scale accelerator, which means they can accelerate electrons moving through a much smaller space. “The size of these devices is uncannily small,” Byer says. The electrons in the new accelerator, for example, travel along a channel that is about three one-thousandths of a millimeter wide—around half the width of a human red blood cell.
Although laser-driven devices can accelerate electrons in a much smaller space than full-scale accelerators, they also require much greater precision to line up the laser and the electrons in the right way, so the light waves push the particles in the correct direction with as much energy as possible. “You not only have to demonstrate the ability to couple the laser light to the electrons in these very small structures, but you have to generate the electrons and have them also be transmitted by the channel,” Byer explains. In 2013 two research groups, one at Stanford and other U.S. institutions and another in Germany, independently managed to accelerate electrons with lasers. But these proof-of-concept prototypes required separate devices to generate the electrons, and they would be difficult to manufacture in bulk using existing techniques.
Image Credit: Neil Sapra
News This Week
There is no vaccine or specific treatment for COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. Since the outbreak began in late 2019, researchers have been racing to [...]
Corona Virus (COVID 19) Interview with Michael Osterholm an expert in infectious disease epidemiology.
Michael Osterholm is an internationally recognized expert in infectious disease epidemiology. He is Regents Professor, McKnight Presidential Endowed Chair in Public Health, the director of the Center for Infectious Disease Research and Policy [...]
With the new coronavirus spreading from person to person (possibly including from people without symptoms), reaching four continents, and traveling faster than SARS, driving it out of existence is looking increasingly unlikely. It’s still [...]
Wake Forest Institute for Regenerative Medicine (WFIRM) scientists have improved upon the 3D bioprinting technique they developed to engineer skeletal muscle as a potential therapy for replacing diseased or damaged muscle tissue, moving another [...]
An international team of scientists from the University of Southampton, the University of Padova, and the University of Zurich has connected a silicon neuron to a neuron from the rat hippocampus with an artificial [...]
In an insightful 42-minute interview, NMIN’s Scientific Director Dr. Pieter Cullis, a pioneer in liposomal gene and drug delivery, discusses his scientific career with a focus on his contributions to the evolution of [...]
A powerful antibiotic that kills some of the most dangerous drug-resistant bacteria in the world has been discovered using artificial intelligence. The drug works in a different way to existing antibacterials and is the [...]
Artificial intelligence hit a big milestone in January — the first drug designed entirely using artificial intelligence entered human clinical trials. The compound, created by Oxford-based biotech company Exscientia, is aimed at treating obsessive-compulsive [...]
Researchers at the Massachusetts General Hospital (MGH) in the US have uncovered the ‘Achilles’ heel’ of most viruses which plague mankind, and could soon develop a universal vaccine. Vaccine research, development and testing takes [...]
Every age in the history of human civilisation has a signature material, from the Stone Age, to the Bronze and Iron Ages. We might even call today’s information-driven society the Silicon Age. Since the [...]
CRISPR gene-edited immune cells have been injected into three people with advanced cancer without any serious side effects, the first trial of its kind in the US. It is also the first CRISPR cancer [...]
“We’ll have nanobots that… connect our neocortex to a synthetic neocortex in the cloud. Our thinking will be a…. biological and non-biological hybrid.” Ray Kurzweil, TED 2014 UPDATE - February 9 2020 Since [...]
Frank Boehm (NanoApps Medical Inc. founder) and Amanda Scott (NA CEO) join NanoApps Athletics Inc. NanoApps Athletics Inc proposes a unique synergistic biochemical/nanomedical strategy for the expedited repair and healing of Achilles tendon micro [...]
In her inaugural podcast, Jamilee interviews Frank Boehm of NanoApps Medical Inc and NanoApps Athletics Inc. From Jamilee's podcast: Welcome to the first episode of "In a Click". On todays show I chat with [...]
Using straightforward chemistry and a mix-and-match, modular strategy, researchers have developed a simple approach that could produce over 65,000 different types of complex nanoparticles, each containing up to six different materials and eight segments, [...]